Oncology & Cancer

Why lung cancer doesn't respond well to immunotherapy

Immunotherapy—drug treatment that stimulates the immune system to attack tumors—works well against some types of cancer, but it has shown mixed success against lung cancer.

Diseases, Conditions, Syndromes

Examining COVID-19's long-term effects on the innate immune system

The more severe the COVID-19 infection, the slower the recovery of immune cells, such as the dendritic cells, which are necessary for the activation of the immune system. This is shown by researchers at Linköping University ...

Immunology

Interleukin-11 found to ameliorate acute colitis in mice

Interleukin (IL)-11 is produced by inflammatory fibroblasts, one of the stromal cells, during acute colitis. Researchers at Toho University Japan found that IL-11 ameliorated acute colitis in mouse models. The IL-11 production ...

Immunology

How the body's B cell academy ensures a diverse immune response

Cells jostling for a spot in a germinal center face a cutthroat admissions process. Formed after exposure to a pathogen or vaccine, germinal centers act as a kind of immune system training academy, helping B cells refine ...

Psychology & Psychiatry

Blood pressure drug holds promise for treating PTSD

There is new evidence that a 50-year-old blood pressure drug could find new purpose as a treatment to mitigate the often life-altering effects of increasingly prevalent PTSD, scientists say.

Oncology & Cancer

Fighting cancer is more efficient at dawn, study finds

The ability of tumors to take hold and grow depends, among other things, on the effectiveness of the immune system in fighting them. Cancer cells, like pathogens, can be identified and targeted by a specific immune response. ...

page 7 from 40